MedTrace Logo

Early Palliative Care Intervention in Malignant Glioma

NCT03471546 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-11-24

No results posted yet for this study

Summary

The purpose of this research study is to determine the feasibility and acceptability of incorporating palliative care into the clinical care plans of patients newly diagnosed with malignant brain tumors. Palliative Care is a field of medicine that focuses on providing relief from symptoms and stress related to serious illnesses. This study will assess the feasibility of conducting a future study, and will gather data upon which to appropriately tailor the intervention and the future study design. The statistical analysis of this study will describe 8 components that encompass each of the 4 areas of focus or "domains": acceptability, demand, implementation, and integration.

Conditions

  • Malignant Glioma

Interventions

BEHAVIORAL

Palliative Care

Initial consultation and follow-up with a palliative care provider

Sponsors & Collaborators

Principal Investigators

  • Katherine Peters, MD, PhD · The Preston Robert Tisch Brain Tumor Center

  • David Casarett, MD, MA · Palliative Care

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-16
Primary Completion
2019-06-17
Completion
2019-06-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471546 on ClinicalTrials.gov